Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Publication year range
1.
Genes Immun ; 16(8): 536-40, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26468780

ABSTRACT

Human host genetic factors have been suggested to be determinants of the prevalence and clinical forms of Chagas disease. In this regard, IL-17A is believed to control parasitemia and protect against heart disease. In this work, we assessed whether IL17A gene polymorphisms are related to infection and/or development of the cardiac form of Chagas disease by genotyping for five IL17A SNPs (rs4711998, rs8193036, rs3819024, rs2275913 and rs7747909) in 1171 individuals from a Colombian region endemic for Chagas disease, classified as seronegative (n=595), seropositive asymptomatic (n=175) and chronic Chagas cardiomyopathy (n=401). Our results showed that SNP rs8193036, which is located upstream of the coding region of the gene, was slightly associated with protection against T. cruzi infection (P=0.0170, P(FDR)=0.0851, odds ratio (OR)=0.80, confidence interval (CI)=0.66-0.96) and associated with protection against the development of cardiomyopathy (P=0.0065, P(FDR)=0.0324, OR=0.75, CI=0.60-0.92). This finding suggests that this IL17A polymorphism could be associated with Trypanosoma cruzi infection and the development of chronic cardiomyopathy due to differential expression of cytokine IL-17A.


Subject(s)
Chagas Cardiomyopathy/genetics , Chagas Cardiomyopathy/immunology , Interleukin-17/genetics , Interleukin-17/immunology , Polymorphism, Single Nucleotide , Chagas Cardiomyopathy/parasitology , Chagas Cardiomyopathy/pathology , Colombia , Genetic Predisposition to Disease , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...